My year chairing the corporate venture group of US trade body the National Venture Capital Association (NVCA) has come to an end, and I am handing the baton to Elaine Jones, venture capital executive director of Pfizer Venture Invest- ments, the venturing unit of the pharmaceutical company. While Global Corporate Venturing now reports the existence…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
